Drug Type Molecular glue |
Synonyms ASHA 044, ASHA044 |
Target |
Mechanism CTNNB1 stimulators(Beta-catenin stimulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Asha Therapeutics LLCStartup |
Active Organization- |
Inactive Organization Asha Therapeutics LLCStartup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | Asha Therapeutics LLCStartup | 20 Oct 2023 |
Hepatocellular Carcinoma | Preclinical | US | Asha Therapeutics LLCStartup | 20 Oct 2023 |